Alimta And Treatment For Mesothelioma Sufferers
EDM number 635 in 2009-10, proposed by Alan Meale on 18/01/2010.
Categorised under the topics of Diseases, Health services and Medicine.
That this House is aware that the anti-cancer drug Alimta is enormously beneficial in the treatment of mesothelioma tumours; recalls that sufferers in Scotland and parts of England and Wales have had access to the drug via cancer networks and primary care trusts; is therefore alarmed that the National Institute of Health and Clinical Excellence (NICE) has indicated that it is not minded to recommend Alimta for prescription to patients despite its known efficacy; and calls on the Government to ignore such advice, which deals mainly with NICE's narrow definition of cost effectiveness rather than the clinical needs of sufferers.
This motion has been signed by a total of 43 MPs.
Download raw data as csv or xml.